Trial Profile
The Efficacy and Safety Study of Magnesium Isoglycyrrhizinate Injection Followed by Diammonium Glycyrrhizinate Enteric-coated Capsules and Combined With Entecavir on the Treatment of Chronic Hepatitis B
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 02 Jun 2020
Price :
$35
*
At a glance
- Drugs Diammonium Glycyrrhizinate (Primary) ; Entecavir (Primary) ; Isoglycyrrhizinate (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- Acronyms MAGIC-101
- Sponsors Chia Tai Tianqing Pharmaceutical Group
- 23 Nov 2017 New trial record